drugset
drugset / Trial / NCT03879837

Therapeutic Equivalence of Fluticasone Propionate Pressurized Metered Dose Inhaler, 110 mcg, to Flovent® HFA 110 mcg

NCT03879837 ↗

Phase 3 Completed 1902 enrolled Actavis Inc. Teva Pharmaceuticals USA · collab
RandomizedParallel-groupQuadruple-blindTreatment

Summary

A Randomized, Blinded, Parallel Group, Placebo-Controlled, Multiple Dose, Multicenter Study to Compare the Therapeutic Equivalence of Fluticasone Propionate Pressurized Metered Dose Inhaler, 110 mcg, to Flovent® HFA 110 mcg, in Adult Subjects with Asthma.

Timeline

Start
2019-03-25
Primary completion
2021-05-28
Completion
2021-07-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Fluticasone propionate Other / unclassified 110 ug Inhaled

Indications

asthma